Form 8-K - Current report:
SEC Accession No. 0001860782-25-000023
Filing Date
2025-03-25
Accepted
2025-03-25 16:10:20
Documents
14
Period of Report
2025-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20250325.htm   iXBRL 8-K 28109
2 EX-99.1 q42024earningspr_03x25x25x.htm EX-99.1 110991
  Complete submission text file 0001860782-25-000023.txt   286511

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20250325.xsd EX-101.SCH 1891
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20250325_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20250325_pre.xml EX-101.PRE 13144
16 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20250325_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 25768381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)